TOKYO: Neurosurgeon Tetsuya Goto had just begun testing a robot to perform brain surgery when he discovered Japan was moving to tighten regulations that would shut down his seven-year project.
Over the next dozen years he watched in frustration as the da Vinci, a rival endoscopic robot that US regulators had already approved, became a commercial success while his and other Japanese prototypes languished in laboratories.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
